Recent advances in the medicinal chemistry of HSV-1 inhibitors (2020–2025): Emerging targets, modalities, and translational challenges

Qiaomei Zhou, Baohu Li, Yehong Dai, Chunhua Ma, Shenghua Gao, Peng Zhan, Jinfei Yang

Open source

DOI
10.1016/j.ejmech.2026.119357
Published
2026-12
Container
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.119357,
  title = {Recent advances in the medicinal chemistry of HSV-1 inhibitors (2020–2025): Emerging targets, modalities, and translational challenges},
  author = {Qiaomei Zhou and Baohu Li and Yehong Dai and Chunhua Ma and Shenghua Gao and Peng Zhan and Jinfei Yang},
  year = {2026},
  journal = {European Journal of Medicinal Chemistry},
  doi = {10.1016/j.ejmech.2026.119357},
  url = {https://doi.org/10.1016/j.ejmech.2026.119357}
}

RIS

TY  - JOUR
TI  - Recent advances in the medicinal chemistry of HSV-1 inhibitors (2020–2025): Emerging targets, modalities, and translational challenges
AU  - Qiaomei Zhou
AU  - Baohu Li
AU  - Yehong Dai
AU  - Chunhua Ma
AU  - Shenghua Gao
AU  - Peng Zhan
AU  - Jinfei Yang
PY  - 2026
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2026.119357
UR  - https://doi.org/10.1016/j.ejmech.2026.119357
ER  - 

APA

Zhou, Q., Li, B., Dai, Y., Ma, C., Gao, S., Zhan, P., & Yang, J. (2026). Recent advances in the medicinal chemistry of HSV-1 inhibitors (2020–2025): Emerging targets, modalities, and translational challenges. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2026.119357

Source records